Tuesday, September 25, 2018
Company News: Page (1) of 1 - 08/08/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Rigel Announces Second Quarter 2018 Financial Results and Provides Company Update
$1.8 Million in Net Product Sales for TAVALISSE™ (fostamatinib disodium hexahydrate)Conference Call and Webcast Today at 5:00PM Eastern Time
(August 08, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:USA, Inc.,Medicine,Disease,Pregnancy,Surgery,Medication,Pregnancy,Physician,Science,Lifestyle,Medical,Cancer,Family,Other,Medical Professionals,Women,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines